The primary estrogen used in menopausal hormone therapy and gender-affirming care — every delivery form, what the modern evidence actually shows, and how to work with a knowledgeable provider.
Estradiol (E2) is the most biologically active estrogen in the human body. Pharmaceutical estradiol is bioidentical — structurally identical to what ovaries produce — and comes in many delivery forms: oral tablets, transdermal patches, topical gels/creams, vaginal preparations, and injectable esters (cypionate, valerate).
Prescription-only in all forms. Used for menopausal symptom management, prevention of postmenopausal osteoporosis, gender-affirming care for transgender women, and fertility treatment support.
FDA approved for multiple indications. Prescription only. Not WADA prohibited for women; context-dependent for men.
Binds ER-α and ER-β throughout the body — reproductive tract, bone, brain, skin, cardiovascular system. Regulates hundreds of downstream genes.
Oral estradiol goes through first-pass liver metabolism — drives up clotting factors and SHBG, increases VTE risk. Transdermal (patch, gel) bypasses the liver and has lower VTE risk while providing the same therapeutic effects. Modern menopause guidelines favor transdermal for most patients.
Any woman with an intact uterus using estradiol must pair it with progesterone (cyclically or continuously) to protect the endometrium from unopposed estrogen.
| Benefit | Evidence |
|---|---|
| Vasomotor symptoms | Most reliable benefit of menopausal HRT; 70–90% reduction in hot flashes and night sweats |
| Genitourinary syndrome | Vaginal dryness, atrophy, recurrent UTIs respond dramatically to topical or systemic estrogen |
| Bone density | Prevents postmenopausal bone loss; reduces fracture risk |
| Cardiovascular | Started before 60 / within 10 yr of menopause (the "timing hypothesis"): neutral or beneficial; started later: possibly harmful |
| Mood & sleep | Improved in peri/postmenopausal women with mood-related symptoms |
| Cognitive function | Critical-window hypothesis: HRT near menopause may protect cognition; starting much later may not help |
The Women’s Health Initiative’s original negative findings have been substantially re-interpreted by the modern literature: most WHI participants were >60 and >10 years postmenopausal, and used oral conjugated equine estrogens plus medroxyprogesterone acetate. That’s not modern transdermal estradiol + micronized progesterone, and the risk profiles differ.
Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.
Start Tracking FreeEstradiol (sensitive assay), SHBG, LH/FSH (if fertility concerns), lipid panel, annual breast and pelvic exam, mammography per guidelines. Labs are helpful but symptom response is the primary guide — don’t chase numbers at the expense of how the patient feels.
Pre-filled with a typical Estradiol setup. Edit any field — the draw updates live.
Insulin syringe — 100 units = 1 mL
Free account. Saves your reconstitution + schedules doses + tracks every vial.
Dosing cheat sheet, reconstitution reference, and cycle planning — delivered to your inbox.
Estradiol is a prescription medication. StackTrax does not sell, prescribe, or facilitate purchase of prescription drugs.
Find a clinician who can order baseline lab work, screen for contraindications, monitor your response, and adjust dosing over time. Options to consider:
Before starting, you’ll typically want:
Avoid sources that offer prescription medications without labs, medical history, or licensed-provider oversight. If a telehealth service promises a prescription after a 5-minute questionnaire, that’s a red flag.
Build your protocol, log every dose, monitor your body's response, and get reminders so you never miss a dose.
Start Tracking FreePharmaceutical estradiol comes in many delivery forms: oral tablets (Estrace), transdermal patches (Vivelle-Dot, Climara), topical gels and creams (Divigel, EstroGel), vaginal preparations (cream, ring, tablet), and injectable esters (cypionate, valerate). All are bioidentical — structurally identical to what ovaries produce — and prescription-only in every form. Modern menopause guidelines favor transdermal for most patients because it bypasses first-pass liver metabolism.
Yes, meaningfully. Pharmaceutical estradiol (E2) is bioidentical — structurally identical to the estrogen ovaries produce. Older HRT trials like the Women's Health Initiative predominantly used oral conjugated equine estrogens plus medroxyprogesterone acetate (synthetic progestin), not modern transdermal estradiol plus micronized progesterone. The WHI's original negative findings have been substantially re-interpreted because the risk profiles differ between these regimens, and because most WHI participants were over 60 and more than 10 years postmenopausal.
Injectable estradiol esters (cypionate, valerate) are commonly used in gender-affirming care, and other delivery forms are also used in this context. Dosing is provider-directed and individualized — this guide focuses on the menopausal HRT dosing ranges and does not specify gender-affirming care protocols. For trans women, access typically goes through a gender-affirming care clinic or endocrinologist familiar with the protocols.
It depends on the patient, but the meaningful distinction is oral vs non-oral. Oral estradiol goes through first-pass liver metabolism, which drives up clotting factors and SHBG and increases VTE risk. Transdermal (patch, gel) bypasses the liver and has lower VTE risk while providing the same therapeutic effects. Modern menopause guidelines favor transdermal for most patients. Injectable estradiol esters are used in gender-affirming care and some HRT protocols and are provider-dosed.
Any woman with an intact uterus using estradiol must pair it with progesterone (cyclically or continuously) to protect the endometrium from unopposed estrogen, which can drive endometrial hyperplasia and cancer over time. Women who have had a hysterectomy do not need progesterone for endometrial protection, though some still take it for other benefits like sleep and mood support.
The modern view is much more favorable than the original WHI interpretation. Started before age 60 or within 10 years of menopause (the timing hypothesis), HRT appears cardiovascular-neutral or beneficial; started later, it may be harmful. Active breast cancer, estrogen-sensitive tumors, undiagnosed vaginal bleeding, active thromboembolic disease, recent stroke or MI, and active liver disease are contraindications. Use caution with family history of breast cancer, hypertriglyceridemia (oral form), migraines with aura, and gallbladder disease.
Disclaimer: This guide is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. The compounds discussed are not FDA approved for human use. Always consult a qualified healthcare provider before starting any new supplement or peptide protocol. StackTrax does not sell peptides or supplements directly — purchase links go to third-party vendors. StackTrax is not responsible for the products, quality, or business practices of any third-party vendor. This page contains affiliate links — StackTrax may earn a commission on purchases at no extra cost to you.
© 2026 StackTrax, LLC. All rights reserved.
StackTrax guides cover peptides and compounds that are not FDA-approved for the uses discussed. The dosing, reconstitution, and safety information is compiled from published research and community protocols for educational purposes only.
Before using any compound mentioned here, consult a qualified healthcare provider. StackTrax does not sell, prescribe, or recommend these substances for personal use.
These pages also contain affiliate links. We may earn a commission on purchases at no extra cost to you — this never changes our editorial recommendations.